Royalty Pharma plc (RPRX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.254% |
| Hold Price * : | $47.97 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Add 9.30% | 310,041 | 0.55 | |
| ≡ | Pat Dorsey - Dorsey Asset Management | Add 0.76% | 17,101 | 0.07 | |
| Q4 2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Add 6.92% | 215,825 | 0.32 | |
| ≡ | Torray Funds | Add 5.90% | 41,472 | 0.25 | |
| Q3 2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Add 4.35% | 129,862 | 0.18 | |
| ≡ | Torray Funds | Add 2.05% | 14,107 | 0.07 | |
| ≡ | Pat Dorsey - Dorsey Asset Management | Buy | 2,350,449 | 7.45 | |
| Q2 2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Add 0.52% | 15,342 | 0.02 | |
| Q1 2025 | |||||
| ≡ | Torray Funds | Add 26.02% | 178,011 | 0.83 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 3.39% | 97,557 | 0.16 | |
| Q4 2024 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Add 40.85% | 833,894 | 0.98 | |
| ≡ | Viking Global Investors | Add 0.94% | 113,864 | 0.01 | |
| Q3 2024 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Add 43.30% | 616,805 | 0.86 | |
| ≡ | Torray Funds | Add 23.70% | 164,361 | 0.65 | |
| ≡ | Viking Global Investors | Add 1.04% | 123,963 | 0.01 | |
| Q2 2024 | |||||
| ≡ | Viking Global Investors | Add 4.22% | 484,511 | 0.05 | |
| ≡ | Torray Funds | Add 3.51% | 23,498 | 0.09 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 0.32% | 4,572 | 0.01 | |
| Q1 2024 | |||||
| ≡ | Torray Funds | Add 32.49% | 164,320 | 0.75 | |
| ≡ | Viking Global Investors | Add 13.86% | 1,398,130 | 0.16 | |
| ≡ | Samantha McLemore - Patient Capital Management | Add 13.15% | 165,038 | 0.24 | |
| Q4 2023 | |||||
| ≡ | Torray Funds | Add 22.56% | 93,107 | 0.42 | |
| ≡ | Viking Global Investors | Add 6.58% | 623,216 | 0.06 | |
| ≡ | Samantha McLemore - Patient Capital Management | Buy | 1,254,780 | 1.87 | |
| Q2 2023 | |||||
| ≡ | Torray Funds | Add 201.68% | 276,643 | 1.47 | |
| Q1 2023 | |||||
| ≡ | Viking Global Investors | Add 11.95% | 1,195,738 | 0.20 | |
| Q3 2022 | |||||
| ≡ | Torray Funds | Add 0.01% | 12 | 0.00 | |
| Q2 2022 | |||||
| ≡ | Viking Global Investors | Add 14.92% | 1,606,222 | 0.31 | |
| ≡ | Torray Funds | Add 5.26% | 6,942 | 0.06 | |
| Q1 2022 | |||||
| ≡ | Viking Global Investors | Add 4.35% | 449,094 | 0.07 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Add 149.13% | 6,174,870 | 0.71 | |
| ≡ | Torray Funds | Buy | 137,941 | 0.81 | |
| Q3 2021 | |||||
| ≡ | Viking Global Investors | Add 27.85% | 901,854 | 0.09 | |
| ≡ | Warren Buffett - Berkshire Hathaway | Buy | 13,145,902 | 0.16 | |
| Q2 2021 | |||||
| ≡ | Viking Global Investors | Add 57.08% | 1,176,901 | 0.15 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 7,342 | 0.00 | |
| Q4 2020 | |||||
| ≡ | Viking Global Investors | Add 17.40% | 338,936 | 0.05 | |
| Q2 2020 | |||||
| ≡ | Viking Global Investors | Buy | 2,514,985 | 0.53 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.